(Q36992961)

17 August 2017

1 reference

title

The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer (English)

1 reference

17 August 2017

1 reference

Kathleen Y Wolin

2

0 references

Ted A Skolarus

series ordinal

1

object named as

Ted A Skolarus

1 reference

17 August 2017

Robert L Grubb

3

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

17 August 2017

published in

Nature Reviews Urology

1 reference

17 August 2017

volume

4

1 reference

17 August 2017

issue

11

1 reference

17 August 2017

page(s)

605-614

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpuro0944

17 August 2017

exact match

0 references

cites work

Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

Prevalence of overweight and obesity in the United States, 1999-2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

The association of body mass index and prostate-specific antigen in a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Does Body Mass Index Affect Preoperative Prostate Specific Antigen Velocity or Pathological Outcomes After Radical Prostatectomy?

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Prostate specific antigen in a community-based sample of men without prostate cancer: correlations with prostate volume, age, body mass index, and symptoms of prostatism.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Influence of age, anthropometry, and hepatic and renal function on serum prostate-specific antigen levels in healthy middle-age men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Anthropometry and prostate cancer risk: a prospective study of 22,248 Norwegian men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Body size and composition and prostate cancer risk: systematic review and meta-regression analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Obesity and prostate cancer: making sense out of apparently conflicting data

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Prostate cancer and body size at different ages: an Italian multicentre case-control study

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Obesity before age 30 years and risk of advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Obesity and prostate cancer screening in the USA

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Outcome of sextant biopsy according to gland volume

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE).

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Obesity does not adversely affect health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Obesity adversely affects health related quality of life before and after radical retropubic prostatectomy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Impact of obesity on clinical outcomes in robotic prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Obesity and capsular incision at the time of open retropubic radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Predicting blood loss and transfusion requirements during radical prostatectomy: the significant negative impact of increasing body mass index

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Influence of body weight and prostate volume on intraoperative, perioperative, and postoperative outcomes after radical retropubic prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Radical perineal prostatectomy for treatment of localized prostate cancer in obese and nonobese patients: a matched control study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Radical perineal prostatectomy for the treatment of localized prostate cancer in morbidly obese patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

The impact of obesity on laparoscopic radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Laparoscopic radical prostatectomy and body mass index: an assessment of 151 sequential cases.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Laparoscopic radical prostatectomy--an analysis of factors affecting operating time.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Impact of prostate size and body mass index on perioperative morbidity after laparoscopic radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Laparoscopic radical prostatectomy: a multi-institutional study of conversion to open surgery

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Robotic-assisted laparoscopic prostatectomy in overweight and obese patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Does obesity influence the operative course or complications of robot-assisted laparoscopic prostatectomy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

A pilot study analyzing PSA, serum testosterone, lipid profile, body mass index and race in a small sample of patients with and without carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

The "skinny" on obesity and prostate cancer prognosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Prostate brachytherapy in obese patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Influence of body mass index on biochemical outcome after permanent prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0944

7 January 2021

Identifiers

DOI

10.1038/NCPURO0944

1 reference

17 August 2017

1 reference